Wednesday, October 14, 2026

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI premiums for Oura and home builders.

SBUX $109BCMG $39B

Yet Another Value Podcast Oct 14 86 clicks

Oct 14 COHR $52B

Coherent | Management Call

P Equity Research 18 clicks

Oct 14 AMAT $359B

Deep Dive: Applied Materials ($AMAT)

Rebound Capital 29 clicks

From X

@aleabitoreddit Sep 20

Serenity on X

@Pau1R0b $RDDT will probably get more accounts + revenue from AI bots that act like human so I’d guess earnings beat. Changing public opinion with AI is really bad for democracy and long term platform health though.

@aleabitoreddit Sep 20

Serenity on X

@cchronobreakk I mean Sam Altman was working on iris scan with his World project, so he probably saw it coming. But human verification is probably needed across the board now for each account. $RDDT doesn’t require much so platforms like that are first to be manipulated.

@aleabitoreddit Sep 20

Serenity on X

The internet is now cooked soon? With $RDDT to other social media like X more at risk due to AI. You can have new decision models like Jev making autonomous computer interaction at near $0 cost. (With actions becoming more human-like/adapative) Then LLMs outputs influencing behavior or leading conversations. So at scale, a malicious actor can spawn 50,000,000 bots just roaming the internet, with LLM prompts convincing people + manufacturing public opinion. The main bottleneck would be phone number, IP, account age, maybe hardware for compute + device identifiers (which is extremely cheap still)… rather than LLM cost. I’ve already anecdotally seen short sellers use AI bots to spread negative misinformation about companies like $SIVE. Or bots market ____ account as the best one to follow in the comments. Or as seen with X uncovering 200+ bots manipulating debate about datacenter public opinion. But the scale might be exponentially worse soon. Scary to think about.

@calvinblissett Sep 20 1 click

Calvin Blissett on X

@odynamite @mirror_mystery I run a concentrated portfolio and believe I have higher return opportunities. I have owned $KSPI for a while. I may buy some in small positions to scratch an itch

@aleabitoreddit Sep 20

Serenity on X

@Temptemo95 Thanks for following all this time! Entire training arc from $RDDT to 1M followers on X has been quite a rollercoaster. Guess like I need to start drawing anime and league characters on top of the $INTC or $NBIS charts again.

@aleabitoreddit Sep 20

Serenity on X

While everyone is focused on Bessent/He Lifeng talks today. Or $LITE / $MRVL / $SIVE at ECOC optical conference... I'm just curious why my followers can leave 2K+ comments if I post in Chinese... But if I share something in English: I only get 50 comments. Feels bad anon https://t.co/Pg6fojfMFx

@calvinblissett Sep 20

Calvin Blissett on X

@mirror_mystery $FICO $PDD $UBER $KNSL $BN $KSPI $CPRT $CSU.TO at low $2,000s because of anchoring bias. $FISV. I do not own many of these, just where I think there’s value based on research I have done.

@valuedontlie Sep 20

Colin King on X

Imminent spin-off activity coming: • $CTVA → $VYLR set for Oct 1 • $MOD → $THRM (RMT) set for Oct 1 Behind that we have: • $KBR investor day Nov '26 → spin early '27 • $FLEX investor day Nov '26 → spin early '27 • $GPC investor day Dec '26 → spin early '27

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TEVA $48B

Equity Eagle Oct 14 8 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $88BJBHT $22B

Monte Independent Investment Research Oct 14 14 clicks

Palantir Is Not C3.Ai, But C3.Ai Wrote Its Watch List - Downgrade Palantir To Hold, Sell C3.Ai

Palantir is cut to Hold after a 35% multiple-driven rally, while C3.ai is rated Sell on stalled revenue, expensive valuation and weak…

PLTR $482B

The Alpha Analyst Oct 14 8 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $17B

Latticework by MOI Global Oct 14 14 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B

Latticework by MOI Global Oct 14 14 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B

Latticework by MOI Global Oct 14 12 clicks

Eaton: Strong Backlog And Margin Recovery Support The Buy Case

Eaton’s backlog, data-center, grid and aerospace demand, plus a 450–500 bp H2 2026 Electrical Americas margin recovery, support the growth…

ETN $156B

Value Capital Research Oct 14 7 clicks

Insider activity September 2026

Asian insider buying rose 19% to US$2.4 billion across 930 September transactions, led by Grab CEO Anthony Tan’s US$30 million purchase…

GRAB $12B

Asian Century Stocks Oct 14 6 clicks

Scarcity is the boogey man for ASML, Applied Materials

ASML’s strong quarterly results failed to prevent a selloff, as AI investors focused on scarcity fears facing chip-equipment makers…

AMAT $359B

The Technology Letter Oct 13 8 clicks

Expert Call | Corning

Corning’s NVIDIA-backed 10x fiber expansion, enterprise connector demand and carrier capacity plans frame its optical communications…

GLW $115B

P Equity Research Oct 13 38 clicks

WDC · long

Western Digital CORP

Western Digital, a hard-disk manufacturer, is pitched as a long after significant share-price moves deter investors.

WDC $124B

Value Investors Club Jul 16 5 clicks

Rollins (ROL), Verisure (VSURE), and the cost of standing still (Part 2, Verisure)

Verisure’s 6.38 million monitored-alarm subscribers generate 90% recurring revenue, while its disclosed acquisition costs and 6%-8% churn…

ROL $15B

Best Anchor Stocks Oct 13 24 clicks

BridgeBio: Maintaining 'Strong Buy' Additional Encaleret Data ADH1 And Three Expected FDA Reviews

BridgeBio Pharma reported Q2 revenue of $243.7 million and has three Priority Review NDAs, while $1 billion in convertible preferred…

BBIO $13B

Terry Chrisomalis Oct 13 2 clicks

Expectations going higher for Everpure, DigitalOcean

Everpure and DigitalOcean face rising expectations as their stock prices shape Monday’s views.

DOCN $13B

The Technology Letter Oct 12 6 clicks

Vicor Update, Part Two

Vicor uses ITC exclusion-order cases to license power-module patents, with published royalty multipliers rising from 1.0x before filing to…

VICR $10B

CV's Substack Oct 12 4 clicks

Rubrik (NYSE: RBRK) Stock Rating: DISTRIBUTE After Q2 FY1/27 Earnings

Rubrik posted 38% Q2 revenue growth to $427.3 million, but Cloud ARR growth slowed to 39% and its enterprise value reached 15.7 times…

RBRK $25B

Cestrian Capital Research Oct 12 3 clicks

Expert Call | Nebius

Nebius’s 1 GW annual active-capacity target from 2027 is realistic, according to a former product manager, with greenfield data centers…

NBIS $56B

P Equity Research Oct 12 4 clicks

Dell's Tailwinds

Dell booked $131.7B of AI server orders in four quarters and held a $95B backlog as enterprise AI demand accelerates.

DELL $301B

Chipstrat Oct 12 4 clicks

Q3 2026 Jenga IP Quarterly Letter

Jenga Global Master Fund returned 8.10% in Q3 2026, added Adobe and Mexican airports, and later initiated S&P Global.

ADBE $98B

Global Outperformers Oct 12 3 clicks

LQDA: finer powder, higher doses

Liquidia’s Yutrepia sales reached $170.4 million in Q2 2026, while a patent ruling threatens its PH-ILD label but leaves PAH sales and a…

UTHR $24B

Trade Ideas Flow Oct 12 4 clicks

Wednesday, October 14, 2026

Serenity on X

Serenity on X

Serenity on X

Calvin Blissett on X

Serenity on X

Serenity on X

Calvin Blissett on X

Colin King on X

Investor Letters

Publications we follow

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 235

X accounts we follow

Investor letters we follow

Sectors